SurvivorNet on MSN
Could timing give your cancer treatment a boost? New study on the best time to receive ...
A new randomized clinical trial showed that receiving immunochemotherapy infusions earlier in the day may help patients with ...
Central retinal artery occlusion can result in permanent vision loss. Effective treatment is lacking. We conducted a phase 3, double-blind, double-dummy, randomized, controlled trial involving ...
Phase II Dose-Randomized Study of Sunvozertinib in Platinum-Pretreated Non–Small Cell Lung Cancer With Epidermal Growth Factor Receptor Exon 20 Insertion Mutations (WU-KONG1B) Patients with unresected ...
Alphamab Oncology (Stock Code: 9966.HK) announced that the results from a phase III clinical study for the treatment of HER2-positive gastric or gastroesophageal junction cancer (GC/GEJ) of ...
The U.S. is giving $1.6 million to researchers to study how the hepatitis B vaccine affects newborns in Guinea-Bissau. Local ...
Abemaciclib Plus Fulvestrant in Advanced Breast Cancer After Progression on CDK4/6 Inhibition: Results From the Phase III postMONARCH Trial Patients with stage III to IV or recurrent, radiographically ...
The study, which assessed the pharmacokinetics, safety, tolerability and immunogenicity of AVT80 compared to Entyvio® in ...
Current drugs for pancreatic cancer lose effectiveness within months because the tumour becomes resistant. The group from ...
News-Medical.Net on MSN
Regular aerobic exercise slows a key marker of brain aging in midlife
By Dr. Sanchari Sinha Dutta, Ph.D. A year of consistent aerobic activity didn’t just boost fitness; it shifted MRI -based brain age in early to midlife adults, suggesting exercise may help preserve ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果